Smith BD - Search Results

1

Economic burden associated with acute myeloid leukemia treatment.

Zeidan AM, Mahmoud D, Kucmin-Bemelmans IT, Alleman CJ, Hensen M, Skikne B, Smith BD. Zeidan AM, et al. Among authors: smith bd. Expert Rev Hematol. 2016 Jan;9(1):79-89. doi: 10.1586/17474086.2016.1112735. Epub 2015 Nov 14. Expert Rev Hematol. 2016. PMID: 26568358 Review.

2

Inhibited apoptosis and drug resistance in acute myeloid leukaemia.

Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones RJ. Smith BD, et al. Br J Haematol. 1998 Sep;102(4):1042-9. doi: 10.1046/j.1365-2141.1998.00854.x. Br J Haematol. 1998. PMID: 9734656 Free article.

3

Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia.

Gladstone DE, Bedi A, Miller CB, Noga SJ, Griffin CA, Piantadosi S, Cagnoni PJ, Brodsky RA, Smith BD, Douglas TT, Shpall EJ, Jones RJ. Gladstone DE, et al. Among authors: smith bd. Biol Blood Marrow Transplant. 1999;5(6):394-9. doi: 10.1016/s1083-8791(99)70016-9. Biol Blood Marrow Transplant. 1999. PMID: 10595817 Free article. Clinical Trial.

4

A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations.

Levis M, Tse KF, Smith BD, Garrett E, Small D. Levis M, et al. Among authors: smith bd. Blood. 2001 Aug 1;98(3):885-7. doi: 10.1182/blood.v98.3.885. Blood. 2001. PMID: 11468194 Free article.

5

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Smith BD, Levis M, Beran M, Giles F, Kantarjian H, Berg K, Murphy KM, Dauses T, Allebach J, Small D. Smith BD, et al. Blood. 2004 May 15;103(10):3669-76. doi: 10.1182/blood-2003-11-3775. Epub 2004 Jan 15. Blood. 2004. PMID: 14726387 Free article. Clinical Trial.

6

Curing acute myelogenous leukemia: still a major challenge.

Smith BD, Karp JE. Smith BD, et al. Leuk Res. 2005 Jun;29(6):607-8. doi: 10.1016/j.leukres.2004.11.026. Epub 2005 Mar 29. Leuk Res. 2005. PMID: 15863198 No abstract available.

7

Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.

Gore SD, Smith BD, Gojo I, Grever M, Kaufmann SH, Letendre L, Leonard DG, Marcucci G, Miller CB, Morris L, Piantadosi S, Prior T, Stock W, Karp JE. Gore SD, et al. Among authors: smith bd. Am J Hematol. 2005 Jun;79(2):119-27. doi: 10.1002/ajh.20354. Am J Hematol. 2005. PMID: 15929100 Free article.

8

New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.

Bao T, Smith BD, Karp JE. Bao T, et al. Among authors: smith bd. Clin Adv Hematol Oncol. 2005 Apr;3(4):287-96, 302. Clin Adv Hematol Oncol. 2005. PMID: 16167001 Review.

9

New concepts in the treatment of acute myeloid malignancies: selected pathways for targeted therapy.

Smith BD, Bao T, Karp JE. Smith BD, et al. J Biol Regul Homeost Agents. 2005 Jan-Jun;19(1-2):23-32. J Biol Regul Homeost Agents. 2005. PMID: 16178271 Review.

10

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

Gore SD, Baylin S, Sugar E, Carraway H, Miller CB, Carducci M, Grever M, Galm O, Dauses T, Karp JE, Rudek MA, Zhao M, Smith BD, Manning J, Jiemjit A, Dover G, Mays A, Zwiebel J, Murgo A, Weng LJ, Herman JG. Gore SD, et al. Among authors: smith bd. Cancer Res. 2006 Jun 15;66(12):6361-9. doi: 10.1158/0008-5472.CAN-06-0080. Cancer Res. 2006. PMID: 16778214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,101 results

Search Page